Ankur Dhingra, CFO: Summit Therapeutics SMMT Buy · Filed 24/03/27

Trade details

Type: Insider buy
Amount: $375,000
Shares · price: 100,000 sh · $3.75 a share
Held after: 354,958 sh
Stock: Summit Therapeutics SMMT
Person: Ankur DhingraCFO
Trade date: 24/03/26
Filed: 24/03/27
Days to filing: 1 days

First buy since 2023

Insiders buying this week: 2 insiders
Holding change: +39.2%

Summit Therapeutics trades, last 26 weeks

What else happened in Summit Therapeutics around then

Filed or reported within 30 days of the trade day · 24/02/25~24/04/25

Ankur Dhingra's recent trades

Ankur DhingraSVP, CFO
BuyIllumina
Buy
Illumina
ILMN
$495.4K
6,100 sh
$495.4K
Filed 25/05/14
Traded 25/05/12
Ankur DhingraCFO
BuySummit Therapeutics
Buy
Summit Therapeutics
SMMT
$42.7K
19,700 sh
$42.7K
Filed 23/12/13
Traded 23/12/13
Ankur DhingraCFO
BuySummit Therapeutics
Buy
Summit Therapeutics
SMMT
$1,505
700 sh
$1,505
Filed 23/12/13
Traded 23/12/13
Ankur DhingraCFO
BuySummit Therapeutics
Buy
Summit Therapeutics
SMMT
$206.2K
196,362 sh
$206.2K
Filed 23/03/08
Traded 23/03/07
Ankur DhingraCFO
BuySummit Therapeutics
Buy
Summit Therapeutics
SMMT
$23.9K
24,658 sh
$23.9K
Filed 23/03/08
Traded 22/08/16